The FDA's lax oversight of research in developing countries can do harm to vulnerable participants
The Food and Drug Administration provides less stringent oversight of overseas research trials used in deciding whether to approve a drug than those conducted domestically. That was the finding of my recent study, published ...
Nov 15, 2021
0
1